BA, University of California at San Diego; MBA, Northwestern University; postgraduate studies in Neurobiology, Salk Institute. 1995-98, Director, President and Chief Operating Officer, SEQUUS Pharmaceuticals, a biopharmaceutical company that was acquired by ALZA Corporation. 1998-2010, Managing Director, ARCH Venture Partners, a venture capital firm; instrumental in the start-up, development and financing of numerous ARCH portfolio companies, including BIND Therapeutics. Since January 2010, President and Chief Executive Officer, BIND Therapeutics.